Hormone replacement therapy and Parkinson’s disease risk in women: a meta-analysis of 14 observational studies

Peifu Wang, Jilai Li, Shi Qiu, Honfeng Wen, Jichen DuDepartment of Neurology, Aerospace Center Hospital, Peking University Aerospace Clinical College, Beijing, People’s Republic of ChinaBackground and purpose: Published data on the relationship of hormone replacement therapy (HRT) with Pa...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Wang P, Li J, Qiu S, Wen H, Du J
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2014
Materias:
Acceso en línea:https://doaj.org/article/5bd63efc854145f5822a97fbec8d04ea
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:5bd63efc854145f5822a97fbec8d04ea
record_format dspace
spelling oai:doaj.org-article:5bd63efc854145f5822a97fbec8d04ea2021-12-02T04:22:44ZHormone replacement therapy and Parkinson’s disease risk in women: a meta-analysis of 14 observational studies1178-2021https://doaj.org/article/5bd63efc854145f5822a97fbec8d04ea2014-12-01T00:00:00Zhttp://www.dovepress.com/hormone-replacement-therapy-and-parkinsonrsquos-disease-risk-in-women--peer-reviewed-article-NDThttps://doaj.org/toc/1178-2021 Peifu Wang, Jilai Li, Shi Qiu, Honfeng Wen, Jichen DuDepartment of Neurology, Aerospace Center Hospital, Peking University Aerospace Clinical College, Beijing, People’s Republic of ChinaBackground and purpose: Published data on the relationship of hormone replacement therapy (HRT) with Parkinson’s disease (PD) were inconclusive. Thus, a systematic meta-analysis of observational studies was performed to clarify this topic.Methods: The databases of PubMed and EMBASE were searched for case–control or cohort studies published up till June 2, 2014. Meta-analysis of the relative risks (RRs) with 95% confidence intervals (CIs) was estimated using random-effects models.Results: A final total of ten case–control and four cohort studies were included in our meta-analysis. The overall combined RR of PD for ever users versus never users of HRT was 1.00 (95% CI: 0.84–1.20). Limited to those subjects who only use estrogen, a similar trend was detected (RR: 0.95, 95% CI: 0.69–1.30). In the subgroup analysis by study design, no significant association was observed in case–control studies (RR: 0.79, 95% CI: 0.62–1.02), whereas a positive association was found in cohort studies (RR: 1.24, 95% CI: 1.10–1.40). In further analysis according to study quality, an inverse association was found in the low-quality group (RR: 0.58, 95% CI: 0.40–0.82), whereas a positive association was found in the high-quality group (RR: 1.16, 95% CI: 1.02–1.31).Conclusion: In summary, our results of meta-analysis do not support a protective role of HRT in female PD development.Keywords: Parkinson’s disease, hormone replacement therapy, hormone meta-analysisWang PLi JQiu SWen HDu JDove Medical PressarticleNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENNeuropsychiatric Disease and Treatment, Vol 2015, Iss default, Pp 59-66 (2014)
institution DOAJ
collection DOAJ
language EN
topic Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
spellingShingle Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
Wang P
Li J
Qiu S
Wen H
Du J
Hormone replacement therapy and Parkinson’s disease risk in women: a meta-analysis of 14 observational studies
description Peifu Wang, Jilai Li, Shi Qiu, Honfeng Wen, Jichen DuDepartment of Neurology, Aerospace Center Hospital, Peking University Aerospace Clinical College, Beijing, People’s Republic of ChinaBackground and purpose: Published data on the relationship of hormone replacement therapy (HRT) with Parkinson’s disease (PD) were inconclusive. Thus, a systematic meta-analysis of observational studies was performed to clarify this topic.Methods: The databases of PubMed and EMBASE were searched for case–control or cohort studies published up till June 2, 2014. Meta-analysis of the relative risks (RRs) with 95% confidence intervals (CIs) was estimated using random-effects models.Results: A final total of ten case–control and four cohort studies were included in our meta-analysis. The overall combined RR of PD for ever users versus never users of HRT was 1.00 (95% CI: 0.84–1.20). Limited to those subjects who only use estrogen, a similar trend was detected (RR: 0.95, 95% CI: 0.69–1.30). In the subgroup analysis by study design, no significant association was observed in case–control studies (RR: 0.79, 95% CI: 0.62–1.02), whereas a positive association was found in cohort studies (RR: 1.24, 95% CI: 1.10–1.40). In further analysis according to study quality, an inverse association was found in the low-quality group (RR: 0.58, 95% CI: 0.40–0.82), whereas a positive association was found in the high-quality group (RR: 1.16, 95% CI: 1.02–1.31).Conclusion: In summary, our results of meta-analysis do not support a protective role of HRT in female PD development.Keywords: Parkinson’s disease, hormone replacement therapy, hormone meta-analysis
format article
author Wang P
Li J
Qiu S
Wen H
Du J
author_facet Wang P
Li J
Qiu S
Wen H
Du J
author_sort Wang P
title Hormone replacement therapy and Parkinson’s disease risk in women: a meta-analysis of 14 observational studies
title_short Hormone replacement therapy and Parkinson’s disease risk in women: a meta-analysis of 14 observational studies
title_full Hormone replacement therapy and Parkinson’s disease risk in women: a meta-analysis of 14 observational studies
title_fullStr Hormone replacement therapy and Parkinson’s disease risk in women: a meta-analysis of 14 observational studies
title_full_unstemmed Hormone replacement therapy and Parkinson’s disease risk in women: a meta-analysis of 14 observational studies
title_sort hormone replacement therapy and parkinson’s disease risk in women: a meta-analysis of 14 observational studies
publisher Dove Medical Press
publishDate 2014
url https://doaj.org/article/5bd63efc854145f5822a97fbec8d04ea
work_keys_str_mv AT wangp hormonereplacementtherapyandparkinsonrsquosdiseaseriskinwomenametaanalysisof14observationalstudies
AT lij hormonereplacementtherapyandparkinsonrsquosdiseaseriskinwomenametaanalysisof14observationalstudies
AT qius hormonereplacementtherapyandparkinsonrsquosdiseaseriskinwomenametaanalysisof14observationalstudies
AT wenh hormonereplacementtherapyandparkinsonrsquosdiseaseriskinwomenametaanalysisof14observationalstudies
AT duj hormonereplacementtherapyandparkinsonrsquosdiseaseriskinwomenametaanalysisof14observationalstudies
_version_ 1718401246353686528